Skip to content
Saturday 8 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,901.09
+0.31%
DAX
26,319.45
+0.69%
CAC 40
8,714.93
+0.17%
STOXX 50
6,523.86
+0.33%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Wednesday 25 August 2021 11:55 am  |  Updated:  Friday 05 November 2021 3:19 pm

Covid vaccine protection could fall below 50 per cent for the elderly by winter

By: Elena Vardon

Add as a preferred source on Google
A dose of AstraZeneca vaccine is prepared at COVID-19 vaccination centre in the Odeon Luxe Cinema in Maidstone, Britain February 10, 2021. (REUTERS/Andrew Couldridge)

A leading scientist has warned that the protection provided by two doses of the Pfizer and AstraZeneca coronavirus vaccines could fall below 50 per cent for the elderly by the winter months.

The test results from 1.2m users of the Zoe Covid app showed that protection from two jabs starts to wane “even within six months”, according to Professor Tim Spector, lead scientist on the app.

The latest analysis shows the Pfizer jab was 88 per cent effective at preventing coronavirus infection after the second jab. After five to six months, however, it fell to 74 per cent.

For AstraZeneca, protection from the virus dropped from 77 per cent a month after the second dose to 67 per cent four to five months down the line.

He added that the findings could explain the recent breakthrough infections in fully vaccinated people.

“In my opinion, a reasonable worst-case scenario could see protection below 50 per cent for the elderly and healthcare workers by winter,” he added. This could result in increased infections, hospitalisations and deaths.

“We urgently need to make plans for vaccine boosters, and decide if a strategy to vaccinate children is sensible,” Professor Spector said.

He added that waning protection is to be expected and is not a reason to not get vaccinated, as the jab still provides high levels of protection for the majority.

Read more

Fine dining and The Jab: A Michelin dinner with the Ozempic set

Ozempic tablet on a plate highlighting medications role in weight loss and diabetes management in healthcare news.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • Test and Trace
  • Vaccine

Trending Articles

  • WPP slashes jobs as revenue continues to fall

  • Liverpool owners tipped to sell – but not to Amazon boss Bezos – by former CEO

  • Revolut founder’s wealth set to balloon amid talks of share award at $500bn valuation

  • Starling plans to ‘come out swinging’ in diversification bid

  • As it happened: Stocks rise despite new tensions in Strait of Hormuz; Oil price climbs

More from Morning Wire

  • Fine dining and The Jab: A Michelin dinner with the Ozempic set

    Life&Style
    Ozempic tablet on a plate highlighting medications role in weight loss and diabetes management in healthcare news.
  • Royal London hits assets record amid pension push

    Investing
    Royal London shared £181mn with its 2.3m customers in April
  • IGI Reports Second Quarter and First Six Months of 2026 Unaudited Financial Results and Declares Ordinary Common Share Dividend

    Business Wire
  • Vapoura Rum: The new English rum taking on the market

    Life&Style
    Vinyl records and Vapoura bottles arranged on a wooden shelf, showcasing a blend of music and vintage decor elements
  • Brits dodge the high street as heatwave boosts online shopping

    Retail
    Shoppers carrying various retail bags, including New Look and M&S Food, on a paved street, indicating retail sales activity.
  • Tour de France Femmes: World famous cycling race plunged into bra row

    Sport Business
    Tour de France Femmes avec Zwift banners promoting the Grand Départ in Great Britain 2027
  • Algoma Central Corporation Reports Financial Results for the 2026 Second Quarter

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook